. Author manuscript; available in PMC: 2021 Feb 1.

Published in final edited form as: Amyotroph Lateral Scler Frontotemporal Degener. 2019 Dec 6;21(1-2):42–50. doi: 10.1080/21678421.2019.1697888

Table 1.

Demographic and clinical information of the dataset included in this study. Means of each group are provided with standard deviations in parentheses.

	ALS (n=272)	Controls (n=251)
Females : males	155:117	116:135
Age	58.29 (10.05)	50.89 (13.03)
Total # of Sessions	775	320
Median # of Sessions per subject	2.00 (3.00)	1.00 (1.00)
Onset, spinal : bulbar	228:44	-
Disease duration (months)	28.08 (24.17)	-
ASLFRS-R total	35.41 (7.36)	-
ALSFRS-R bulbar	10.46 (2.15)	-
% FVC	82.85 (22.15)	-
% Intelligibility, SIT	94.11 (14.01)	98.55 (1.22)
Speaking rate, SIT (WPM)	156.23 (41.07)	198.07 (21.80)

ALSFRS-R: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (5); %FVC: % Forced vital capacity; SIT: Speech Intelligibility Test; WPM: Words per minute